AURORA, Colo., Jan. 9, 2025 /PRNewswire/ -- RheumaGen, Inc., a cell and gene therapy company engineering a new class of therapeutics for major autoimmune diseases, announced today the close of a $15 ...
AURORA, Colo., Oct. 28, 2025 /PRNewswire/ -- RheumaGen, Inc., a cell and gene therapy company engineering a new class of therapeutics to cure common autoimmune diseases, today announced groundbreaking ...
Two human leukocyte antigen (HLA) alleles, DRB1*04.04 and DRB1*03, show a significant correlation with myasthenia gravis (MG) prevalence. Northern Europe exhibits the highest prevalence of MG and ...
The adaptive immune system is an antigen-specific structure that discriminates non-self molecules through the recognition of peptide antigens using receptor interactions between T-cells and ...
The Epstein-Barr virus and a high-risk gene may work together to trick the immune system into attacking the brain in MS, a ...
Recent findings suggest that the Epstein-Barr virus (EBV) is involved in both causing multiple sclerosis (MS) and shaping its ...
—Researchers provide the most comprehensive genetic synopsis of primary biliary cholangitis to date, identifying 44 risk-associated variants with strong evidence for novel genome-wide significant loci ...
Season of birth, genetic factors, and early-life infections impact celiac disease autoimmunity risk, with significant effects in children with specific gene variants. The TEDDY study found increased ...
Multiple sclerosis is a disease in which the immune system erroneously attacks a protective insulation that surrounds neurons ...